Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2012
10/03/2012CN102225067B Pharmaceutical composition for treating stomach cancer
10/03/2012CN102218128B Health-care medicinal tea and its preparation method
10/03/2012CN102218056B Use of butenolide I in preparing drugs for controlling immunological liver injury
10/03/2012CN102205027B Medicated wine capable of tonifying kidney and yang and preparation method thereof
10/03/2012CN102204971B Traditional Chinese medicine preparation for preventing and treating stomatopathy and throat diseases
10/03/2012CN102178788B Chinese medicinal composition for reducing transaminase and jaundice and preparation method thereof
10/03/2012CN102138990B Preparation method and new application of traditional Chinese medicine composition for invigorating qi, nourishing liver and clearing away heat and toxic material
10/03/2012CN102125622B Detection method of traditional Chinese medicine preparation for clearing away heat and toxic material, removing food retention and regulating stomach
10/03/2012CN102125550B Ondansetron hydrochloride composition for injection and preparation method thereof
10/03/2012CN102100687B Application of medicine composition with function of exterminating oral helicobacter pylori
10/03/2012CN102058631B Seabuckthorn leaf extract preparation and preparation method thereof
10/03/2012CN102058552B Sofalcone sustained release tablet and preparation method thereof
10/03/2012CN101953884B Fingerprint quality detection method for medicinal composition
10/03/2012CN101934061B Chinese medicinal chewable tables for treating diarrhea and preparation method thereof
10/03/2012CN101933996B Chinese medicinal composition having effects of clearing heat, relieving fire and eliminating toxins and preparation and detection methods thereof
10/03/2012CN101919892B Traditional Chinese medicine compound
10/03/2012CN101912545B Processing method of pinellia rhizome fermented mass
10/03/2012CN101889998B Composition and application thereof as TR3 receptor inducer
10/03/2012CN101879177B Aivlosin for the treatment of disease due to brachyspira pilosicoli or ornithobacterium rhinotracheale
10/03/2012CN101862344B Mouthwash preparation containing nysfungin
10/03/2012CN101845009B Structural carotenoid analogs for the inhibition and amelioration of disease
10/03/2012CN101843677B Chinese medicinal composition for treating hepatitis B and preparation method thereof
10/03/2012CN101837095B American cockroach medicinal composition for curing gastritis and peptic ulcers and preparation method thereof
10/03/2012CN101822712B Pellet for oral administration and external use and preparation process thereof
10/03/2012CN101804027B Granisetron hydrochloride nasal spray and preparation method thereof
10/03/2012CN101708149B Tooth detergent and method for producing same
10/03/2012CN101704792B Quinoxalinone derivative with matrix metalloproteinase inhibitory activity and preparation method and application thereof
10/03/2012CN101676281B Benzo macrolide compound (3R)- des-O-methyllasiodiplodin, its derivatives and preparation method and use
10/03/2012CN101643484B High-purity syringin, preparation method and application
10/03/2012CN101580535B Hcv protease inhibitors
10/03/2012CN101537086B Pharmaceutical composition for resisting hepatitis B virus, lowering lipid and alleviating fatty live lesions and preparation method thereof
10/03/2012CN101518646B Lipase-containing composition
10/02/2012US8278422 Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof
10/02/2012US8278329 Antagonizing N-type calcium channels; use as analgesic, neurodegenerative diseases, brain injury, bronchial asthma, unstable angina and irritable colitis, drug withdrawal symptoms; t-butyl 2-[4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-piperidinyl]-2-oxoethylcarbamate for example
10/02/2012US8278301 2-alkylbenzoxazole carboxamides as 5HT3 modulators
10/02/2012US8278269 Proteins for use in treatment of gastrointestinal disorders; novel gene product designated Antrum Mucosal Protein 18 ("AMP-18") is a gastrokine
10/02/2012US8278103 Oligonucleotides comprising alternating segments and uses thereof
10/02/2012US8277836 Carbohydrates mixture
10/02/2012US8277782 Antiinflammatory agent, metalloproteinase inhibitor, anti-oxidant and modifier of cell redox status, vitamins, inhibitor of activation of nuclear factor kappa beta
10/02/2012CA2576926C Use of midostaurin for treating gastrointestinal stromal tumors
10/02/2012CA2546300C 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
10/02/2012CA2478111C A cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy
10/02/2012CA2466477C A2b adenosine receptor antagonists
10/02/2012CA2406393C Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
09/2012
09/27/2012WO2012129066A2 New targets for treatment of er stress
09/27/2012WO2012128502A2 Composition for promoting vasculogenesis comprising pauf
09/27/2012WO2012128377A1 Composition for treatment and diagnosis of pancreatic cancer
09/27/2012WO2012127878A1 A 5-ht4 receptor agonist as a prokinetic agent
09/27/2012WO2012126386A1 Mixed crystal agomelatine (form-viii), preparation method and use thereof and pharmaceutical composition containing same
09/27/2012WO2012126385A1 New crystal form vii of agomelatine, preparation method and use thereof and pharmaceutical composition containing same
09/27/2012WO2012126178A2 Pharmaceutical composition for treating hepatic disease
09/27/2012WO2012104263A3 1,4 oxazines as bace1 and/or bace2 inhibitors
09/27/2012WO2012069658A4 Immunomodulatory compositions comprising hydralazine for the treatment gastrointestinal disorders
09/27/2012US20120245552 Combination Therapy
09/27/2012US20120245231 Weight based dosing of an oral solution having diphenhydramine, or pharmaceutically acceptable salts thereof, as an active ingredient
09/27/2012US20120245213 Human type i taste receptor subunit 3 modulators and methods of using same
09/27/2012US20120245203 Methods for treating heartburn and/or preventing gastric bleeding or hemorrhage in patients receiving clopidogrel therapy
09/27/2012US20120245194 Small molecule inhibitors of the alpha4-paxillin interaction
09/27/2012US20120245193 PERIPHERIALLY ACTING μ OPIOID ANTAGONISTS
09/27/2012US20120245192 Pharmaceutical formulations containing rifaximin, processes for their obtainment and method of treating intestinal disease
09/27/2012US20120245191 New azaspirodecanone compounds
09/27/2012US20120245181 Opioid receptor ligands and methods of using and making same
09/27/2012US20120245171 Benzpyrazole derivatives as inhibitors of pi3 kinases
09/27/2012US20120245150 NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS p75 INHIBITORS
09/27/2012US20120245149 NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS
09/27/2012US20120245148 Tetrahydroquinoxaline uera derivatives, their preparation and their therapeutic application
09/27/2012US20120245144 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012US20120245138 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides
09/27/2012US20120245120 Zinc sucrose octasulfates, their preparation, and pharmaceutical and cosmetic uses thereof
09/27/2012US20120245113 Clerodane derivatives for modulation of leukotriene receptor activity and related diseases
09/27/2012US20120245110 Vascular leakage inhibitor
09/27/2012US20120245108 Method of modulating complement factor b (cfb) expression in cells
09/27/2012US20120245081 Fas peptide mimetics and uses thereof
09/27/2012US20120245080 Mineral salt-sulfonic acid compositions and methods of use
09/27/2012US20120245077 Prokineticin 1 receptor
09/27/2012US20120244219 Stable benzimidazole formulation
09/27/2012US20120244216 Coated pharmaceutical capsule dosage form
09/27/2012US20120244211 Compositions And Methods For Treatment Of The Side-Effects Associated With Administration Of Cancer Chemotherapeutic Agents
09/27/2012US20120244195 Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease
09/27/2012US20120244191 Compositions and methods for controlling diseases in animals
09/27/2012US20120244188 Treatment of Sensory Disturbance Disorders
09/27/2012US20120244175 Tumor specific animal proteins
09/27/2012US20120244171 Cytotoxic benzodiazepine derivatives
09/27/2012US20120244169 Treatment for Radiation-Induced Disorders
09/27/2012US20120244149 Benzoxazepin pi3k inhibitor compounds and methods of use
09/27/2012US20120244147 Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agents
09/27/2012US20120244139 Modified proteases that inhibit complement activation
09/27/2012US20120244105 Pharmaceutical Compositions Comprising Polymeric Binders with Non-Hydrolysable Covalent Bonds and Their Use in Treating Celiac Disease
09/27/2012US20120244102 Agent for preventing or treating crohn's disease, comprising organic acid polymer
09/27/2012US20120244087 Oral compositions containing a combination of natural extracts and related methods
09/27/2012US20120244086 Oral compositions containing extracts of zingiber officinale and related methods
09/27/2012US20120244085 Oral compositions containing extracts of myristica fragrans and related methods
09/27/2012US20120244069 Human monoclonal antibodies against cd25
09/27/2012CA2830628A1 Composition for treatment and diagnosis of pancreatic cancer
09/27/2012CA2830616A1 Pharmaceutical composition for treating hepatic disease
09/27/2012CA2829690A1 Mixed crystal agomelatine (form-viii), preparation method and use thereof and pharmaceutical composition containing same
09/27/2012CA2829687A1 New crystalline form vii of agomelatine, preparation method and use thereof and pharmaceutical composition containing same
09/27/2012CA2829050A1 A 5-ht4 receptor agonist as a prokinetic agent
09/26/2012EP2502998A2 Recombinant toxin A/ToxinB vaccine against clostridium difficile
09/26/2012EP2502985A1 Method for inducing differentiation of dental pulp cells into odontoblasts
1 ... 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 ... 1258